Switzerland (CH)

Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial (2019) Highland K, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, et al. Conference contribution Effect of Anti-Topoisomerase I Antibody Status on Decline in Lung Function in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Data from the SENSCIS Trial (2019) Mayes M, Highland K, Gahlemann M, Fischer A, Raghu G, Girard M, Alves M, et al. Conference contribution The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases (2019) Matteson E, Kelly C, Distler J, Mann-Vold AMH, Seibold J, Mittoo S, Distler O, et al. Conference contribution Cracking a Novel Profibrotic Molecular Mechanism: lncRNA H19X and DDIT4L Crosstalk (2019) Pachera E, Assass S, Salazar G, Frank-Bertoncelj M, Distler J, Kania G, Distler O Conference contribution Psoriatic Arthritis - Epidemiology, Incidence Rate in Psoriasis Patients, Comorbidity Profiles and Risk Factor Analysis (2019) Rech J, Sticherling M, Biermann M, Haeberle B, Reinhardt M Conference contribution Proteolytic activation of the epithelial sodium channel (ENaC) by heterologous co-expression of catalytically inactive prostasin involves endogenous protease activity in Xenopus laevis oocytes (2019) Diakov A, Ilyaskin A, Staudner T, Hummler E, Korbmacher C Conference contribution Aldosterone-independent ENaC activity in the early part of the aldosterone-sensitive distal nephron critically depends on the presence of mineralocorticoid receptor (2019) Nesterov V, Bertog M, Canonica J, Hummler E, Korbmacher C Conference contribution Overall survival (OS) results of the phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor 2-negative (HER2-) advanced breast cancer (ABC) treated with fulvestrant (FUL) (+) ribociclib (RIB) (2019) Slamon DJ, Neven P, Chia S, Fasching P, De Laurentiis M, Im SA, Petrakova K, et al. Conference contribution Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) (2019) Cossarizza A, Acs A, Adam D, Adam-Klages S, Agace WW, Aghaeepour N, Akdis M, et al. Journal article Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures (2019) Zweier M, Begemann A, Mcwalter K, Cho MT, Abela L, Banka S, Behring B, et al. Conference contribution